Takeda Pharmaceutical Income from Continuous Operations 2010-2024 | TAK
Takeda Pharmaceutical income from continuous operations for the twelve months ending June 30, 2024 was $0.952B, a 56.52% decline year-over-year.
- Takeda Pharmaceutical annual income from continuous operations for 2024 was $0.995B, a 57.59% decline from 2023.
- Takeda Pharmaceutical annual income from continuous operations for 2023 was $2.346B, a 14.53% increase from 2022.
- Takeda Pharmaceutical annual income from continuous operations for 2022 was $2.048B, a 42.07% decline from 2021.